Serum oxidized low-density lipoprotein level as a marker of oxidative stress in patients undergoing hyperbaric oxygen therapy
Kudret Keskin1, Hakan Kilci1, Gökhan Aksan1, Gökhan Çetinkal1, Süleyman Sezai Yıldız1, Füsun Kocaman Türk2, Gülsüm Bingöl31Department of Cardiology, Şişli Hamidiye Etfal Training and Research Hospital, İstanbul, Turkey2Hipermer Hyperbaric Oxygen Therapy Center, Undersea and Hyperbaric Medicine, İstanbul, Turkey
3Department of Cardiology, Private İstanbul Surgery Hospital, İstanbul, Turkey
OBJECTIVE Oxidative stress (OS) is involved in the pathogenesis of atherosclerosis. Hyperbaric oxygen therapy (HBOT), in which 100% oxygen is inhaled under hyperbaric pressure, may create OS. Therefore, the aim of this research was to measure the serum oxidized low-density lipoprotein (oxLDL) level in patients undergoing HBOT.
METHODS Twenty-nine patients who underwent HBOT to treat various diseases were enrolled in this study. The serum oxLDL level was measured at the beginning of the first and after the 10th therapy session.
RESULTS There was no significant difference between the oxLDL level of patients before and after HBOT (4.96±0.1 vs. 4.94±0.1 U/mL; p=0.36).
CONCLUSION HBOT seems to be safe in terms of oxLDL production up to 10 sessions. However, further large-scale studies investigating longer duration of HBOT treatment are required to understand the role of OS.
Kudret Keskin, Hakan Kilci, Gökhan Aksan, Gökhan Çetinkal, Süleyman Sezai Yıldız, Füsun Kocaman Türk, Gülsüm Bingöl. Serum oxidized low-density lipoprotein level as a marker of oxidative stress in patients undergoing hyperbaric oxygen therapy. Turk Kardiyol Dern Ars. 2017; 45(6): 533-537
Corresponding Author: Kudret Keskin, Türkiye
Manuscript Language: English
Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348
Copyright © 2024 Archives of the Turkish Society of Cardiology
